TABROS PHARMA products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Karachi · Pakistan
Pakistan pharmaceutical manufacturer and marketer with a broad branded portfolio and dedicated pharmacovigilance and product-safety functions.
TABROS PHARMA products in Pakistan
TABROS PHARMA (PVT). LTD has 177 medicine presentations registered in Pakistan under 77 brands, covering 64 generic medicines. Most of its products are in Anti-infectives, Cardiovascular and Vitamins, minerals & nutrition. Its brands with the most registered strengths and packs are DENCITY (Ondansetron), LIZOTEK (Linezolid), Colimethate (Colistimethate sodium) and CUTIS (Terbinafine). 177 products have an official DRAP price on MedInfoBase. See all 77 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Tabros Pharma (Pvt.) Ltd.
- Company type
- Private pharmaceutical manufacturer
- Address
- Essa House, 32-1-C, Block-6, P.E.C.H.S., Karachi, Pakistan
- Website
- tabrospharma.com ↗
- Phone
- +92 21 34533416-8
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 88%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where TABROS PHARMA (PVT). LTD. is priced against the market
154 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| ACTOSE | Lactulose | 3.35 g | Syrup | 120ml | 067272 | PKR 201.28 | PKR 1.68/mL | 🔒 Pharma Pro |
| AMPHOCINE-B | Amphotericin B | 50 mg | Lyophilized powder for injection | 1's | 098705 | PKR 1,349.10 | PKR 1,349.10/vial/unit | 🔒 Pharma Pro |
| AMYGRA | Pyridostigmine | 60 mg | Tablet | 2x10's | 023318 | PKR 236.26 | PKR 11.81/tablet | No comparator |
| ANVIRAS | Oseltamivir | 75 mg | Capsule | 10's | 101300 | PKR 1,133.68 | PKR 113.37/capsule | 🔒 Pharma Pro |
| ASCORBIC ACID Ascorbic Acid | Ascorbic acid | 100 mg | Tablet | 1000's | 011864 | PKR 110.10 | PKR 0.11/tablet | 🔒 Pharma Pro |
| AVELAC-C | Ascorbic acid | 300 mg | Chewable tablet | 30's | 025532 | PKR 236.35 | PKR 7.88/tablet | No comparator |
| BISHEART | Bisoprolol fumarate | 2.5 mg | Tablet | 2x7's | 076017 | PKR 59.96 | PKR 4.28/tablet | 🔒 Pharma Pro |
| CEFON | Cefotaxime | 500 mg | Injection | 1vial | 015943 | PKR 167.10 | PKR 167.10/vial/unit | 🔒 Pharma Pro |
| CEFON | Cefotaxime | 250 mg | Injection | 1vial | 015944 | PKR 110.87 | PKR 110.87/vial/unit | 🔒 Pharma Pro |
| CEFON | Cefotaxime | 1 g | Injection | 1vial | 015945 | PKR 300.55 | PKR 300.55/vial/unit | 🔒 Pharma Pro |
| CO-MISOMAL | Artemether + Lumefantrine | 20 mg + 120 mg | Tablet | 24's | 047119 | PKR 941.69 | PKR 39.24/tablet | 🔒 Pharma Pro |
| CO-MISOMAL | Artemether + Lumefantrine | 20 mg + 120 mg | Tablet | 16's | 047119 | PKR 590.91 | PKR 36.93/tablet | 🔒 Pharma Pro |
| CO-MISOMAL | Artemether + Lumefantrine | 80 mg + 480 mg | Tablet | 6'S | 066760 | PKR 681.46 | PKR 113.58/tablet | 🔒 Pharma Pro |
| CO-MISOMAL DS | Artemether + Lumefantrine | 40 mg + 240 mg | Tablet | 8'S | 055449 | PKR 545.21 | PKR 68.15/tablet | 🔒 Pharma Pro |
| CO-MISOMAL DS | Artemether + Lumefantrine | 40 mg + 240 mg | Tablet | 12's | 055449 | PKR 500.77 | PKR 41.73/tablet | 🔒 Pharma Pro |
| CO-ZISCAR | Lisinopril + Hydrochlorothiazide | 20 mg + 12.5 mg | Tablet | 28'S | 048759 | PKR 929.31 | PKR 33.19/tablet | 🔒 Pharma Pro |
| CO-ZISCAR 10 | Lisinopril + Hydrochlorothiazide | 10 mg + 12.5 mg | Tablet | 14'S | 053203 | PKR 278.78 | PKR 19.91/tablet | 🔒 Pharma Pro |
| CO-ZISCAR 20 | Lisinopril + Hydrochlorothiazide | 20 mg + 25 mg | Tablet | 14'S | 053204 | PKR 464.66 | PKR 33.19/tablet | 🔒 Pharma Pro |
| Colimethate | Colistimethate sodium | 1 MIU | Powder for solution for IV injection | 1's | 097181 | PKR 1,199.81 | PKR 1,199.81/vial/unit | 🔒 Pharma Pro |
| Colimethate | Colistimethate sodium | 2 MIU | Powder for solution for IV injection/infusion | 1's | 107733 | PKR 2,000.07 | PKR 2,000.07/vial/unit | 🔒 Pharma Pro |
| Colimethate | Colistimethate sodium | 3 MIU (≈100 mg colistin base activity) | Powder for solution for injection/infusion | 10's | 108905 | PKR 28,806.97 | PKR 2,880.70/vial/unit | No comparator |
| Colimethate | Colistimethate sodium | 3 MIU (≈100 mg colistin base activity) | Powder for injection/infusion | 1's | 108905 | PKR 3,000.68 | PKR 3,000.68/vial/unit | No comparator |
| Colimethate | Colistimethate sodium | 4.5 MIU | Powder for solution for injection | 1's | 120139 | PKR 4,207.10 | PKR 4,207.10/vial/unit | No comparator |
| Consec DDR Capsule 30mgRegistry verified | Dexlansoprazole Dual Delayed Release Pellets eq. to Dexlansoprazole | — | — | — | 108530Official source ↗ | No indexed price | — | — |
| Consec DDR Capsules 60mgRegistry verified | Dexlansoprazole Dual Delayed Release Pellets eq. to Dexlansoprazole | — | — | — | 108531Official source ↗ | No indexed price | — | — |
| CORTICORT | Hydrocortisone | 10 mg | Tablet | 3x10's | 100196 | PKR 169.53 | PKR 5.65/tablet | 🔒 Pharma Pro |
| CRESAR AM | Telmisartan + Amlodipine | 5 mg + 40 mg | Tablet | 14's | 094850 | PKR 669.75 | PKR 47.84/tablet | 🔒 Pharma Pro |
| CRESAR AM | Telmisartan + Amlodipine | 10 mg + 40 mg | Tablet | 20's | 094851 | PKR 999.76 | PKR 49.99/tablet | 🔒 Pharma Pro |
| CRESAR AM | Telmisartan + Amlodipine | 5 mg + 80 mg | Tablet | 20's | 094852 | PKR 1,281.26 | PKR 64.06/tablet | 🔒 Pharma Pro |
| CRESAR AM | Telmisartan + Amlodipine | 10 mg + 80 mg | Tablet | 14's | 094853 | PKR 1,116.25 | PKR 79.73/tablet | 🔒 Pharma Pro |
| CRESAR-H | Telmisartan + Hydrochlorothiazide | 40 mg + 12.5 mg | Tablet | 28's | 055903 | PKR 1,216.30 | PKR 43.44/tablet | 🔒 Pharma Pro |
| CRESAR-H | Telmisartan + Hydrochlorothiazide | 80 mg + 12.5 mg | Tablet | 28's | 055904 | PKR 2,292.26 | PKR 81.87/tablet | 🔒 Pharma Pro |
| CRESAR-H 40 | Telmisartan + Hydrochlorothiazide | 40 mg + 12.5 mg | Tablet | 14's | 055903 | PKR 640.16 | PKR 45.73/tablet | 🔒 Pharma Pro |
| CRESAR-H 80 | Telmisartan + Hydrochlorothiazide | 80 mg + 12.5 mg | Tablet | 14's | 055904 | PKR 1,208.04 | PKR 86.29/tablet | 🔒 Pharma Pro |
| CRESAR-H 80 | Telmisartan + Hydrochlorothiazide | 80 mg + 25 mg | Tablet | 14's | 055905 | PKR 1,218.37 | PKR 87.03/tablet | 🔒 Pharma Pro |
| CUTIS | Terbinafine | 1% w/w (10 mg/g) | Cream | 10 Gm | 035397 | PKR 294.42 | PKR 29.44/g | No comparator |
| CUTIS | Terbinafine | 1% | Gel | 10Gm | 058518 | PKR 204.64 | PKR 20.46/g | No comparator |
| CUTIS | Terbinafine | 1% w/v | Lotion | 20ML | 067109 | PKR 578.22 | PKR 28.91/mL | No comparator |
| CUTIS | Terbinafine | 10 mg | Spray | 30ml | 107447 | PKR 630.29 | PKR 21.01/mL | No comparator |
| CUTIS | Terbinafine | 10 mg | Gel | 120ml | 107447 | PKR 2,318.55 | PKR 19.32/mL | No comparator |
| DACORN | Dexamethasone | 0.5 mg | Tablet | 10x10's | 005315 | PKR 84.41 | PKR 0.84/tablet | 🔒 Pharma Pro |
| DACORN | Dexamethasone | 0.5 mg | Tablet | 1000'S | 005315 | PKR 844.12 | PKR 0.84/tablet | 🔒 Pharma Pro |
| Definity | Cholecalciferol | 5 mg/mL | Injection | 5'sx1ml | 082131 | PKR 796.73 | PKR 159.35/mL | 🔒 Pharma Pro |
| Definity | Cholecalciferol | 5 mg | Injection | 5'sx 1ml | 082131 | PKR 862.33 | PKR 172.47/mL | 🔒 Pharma Pro |
| Definity | Cholecalciferol | 5 mg/mL | Injection | 1'sx1ml | 082131 | PKR 159.34 | PKR 159.34/mL | 🔒 Pharma Pro |
| Definity | Cholecalciferol | 5 mg | Injection | 1'sx 1ml | 082131 | PKR 172.46 | PKR 172.46/mL | 🔒 Pharma Pro |
| DENCITY | Ondansetron | 4 mg | Tablet | 1's | 127029 | PKR 106.56 | PKR 106.56/tablet | 🔒 Pharma Pro |
| DENCITY | Ondansetron | 4 mg | Tablet | 1x10's | 127029 | PKR 1,065.60 | PKR 106.56/tablet | 🔒 Pharma Pro |
| DENCITY | Ondansetron | 8 mg | Tablet | 1x10's | 127030 | PKR 1,775.99 | PKR 177.60/tablet | 🔒 Pharma Pro |
| DENCITY | Ondansetron | 8 mg | Tablet | 1x12's | 127030 | PKR 2,131.19 | PKR 177.60/tablet | 🔒 Pharma Pro |
All 77 TABROS PHARMA brands in Pakistan
- ACTOSE Lactulose · 3.35 g syrup
- AMPHOCINE-B Amphotericin B · 50 mg injection
- AMYGRA Pyridostigmine · 60 mg tablet
- ANVIRAS Oseltamivir · 75 mg capsule
- ASCORBIC ACID Ascorbic Acid Ascorbic acid · 100 mg tablet
- AVELAC-C Ascorbic acid · 300 mg tablet
- BISHEART Bisoprolol fumarate · 2.5 mg tablet
- CEFON Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
- CO-MISOMAL Artemether + Lumefantrine · 20 mg + 120 mg tablet, 80 mg + 480 mg tablet
- CO-MISOMAL DS Artemether + Lumefantrine · 40 mg + 240 mg tablet
- CO-ZISCAR Lisinopril + Hydrochlorothiazide · 20 mg + 12.5 mg tablet
- CO-ZISCAR 10 Lisinopril + Hydrochlorothiazide · 10 mg + 12.5 mg tablet
- CO-ZISCAR 20 Lisinopril + Hydrochlorothiazide · 20 mg + 25 mg tablet
- Colimethate Colistimethate sodium · 1 MIU injection, 2 MIU infusion, 3 MIU (≈100 mg colistin base activity) infusion
- CORTICORT Hydrocortisone · 10 mg tablet
- CRESAR AM Telmisartan + Amlodipine · 10 mg + 40 mg tablet, 10 mg + 80 mg tablet, 5 mg + 40 mg tablet
- CRESAR-H Telmisartan + Hydrochlorothiazide · 40 mg + 12.5 mg tablet, 80 mg + 12.5 mg tablet
- CRESAR-H 40 Telmisartan + Hydrochlorothiazide · 40 mg + 12.5 mg tablet
- CRESAR-H 80 Telmisartan + Hydrochlorothiazide · 80 mg + 12.5 mg tablet, 80 mg + 25 mg tablet
- CUTIS Terbinafine · 1% gel, 1% w/v lotion, 1% w/w (10 mg/g) cream
- DACORN Dexamethasone · 0.5 mg tablet
- Definity Cholecalciferol · 5 mg injection, 5 mg/mL injection
- DENCITY Ondansetron · 4 mg tablet, 4 MG/2 mL injection, 4 mg/5 mL solution
- DEXASONE Dexamethasone · 4 mg injection
- DIARON Gliclazide · 80 mg tablet
- Doxycycline Doxycycline · 100 mg capsule
- E-CLAR Clarithromycin · 250 mg tablet, 500 mg tablet
- E-CLAR DS Clarithromycin · 500 mg tablet
- ELZAFLO Empagliflozin · 10 mg tablet, 25 mg tablet
- FERRY Iron polymaltose complex · 100 mg capsule, 50 mg elemental iron/5 mL syrup, 50 mg/5 mL syrup
- FERRY-F Iron polymaltose complex + Folic acid · 100 mg + 0.35 mg capsule, 100 mg elemental iron + 0.35 mg folic acid capsule
- FIMRA Omeprazole · 20 mg capsule, 40 mg capsule
- FIXITIL Cefixime · 100 mg/5 mL suspension, 400 mg capsule
- FIXITIL DS Cefixime · 200 mg/5 mL suspension
- FIXITIL-T Cefixime · 200 mg tablet
- FIXITIL-T DS Cefixime · 400 mg tablet
- Flurocort Fludrocortisone acetate · 0.1 mg tablet
- Focin Fosfomycin disodium · 1 g/vial injection
- Folic Acid Folic acid · 5 mg tablet
- GAVEL Ciprofloxacin · 125 mg/5 mL suspension, 250 MG tablet, 250 mg/5 mL suspension
- Gentamicin Gentamicin · 40 mg injection
- HALSA Ascorbic acid · 500 mg tablet
- KINRA Azithromycin · 200 mg/5 mL suspension, 250 mg tablet, 500 mg tablet
- Lixpro Tenofovir disoproxil · 300 mg tablet
- LIZOTEK Linezolid · 100 mg/5 mL suspension, 2 mg infusion, 600 mg tablet
- LOMIS Acetylsalicylic acid (Aspirin) · 75 mg tablet
- MECROZ 2% ORAL Miconazole · 2 % gel
- MISOMAL Artemether, Artesunate · 20 mg/mL injection, 40 mg/mL injection, 500 mg tablet
- MISONATE Artesunate · 120 MG injection, 30 MG injection, 60 mg injection
- MIXTE Hydroxychloroquine · 200 mg tablet
- MOXIFO Moxifloxacin · 400 MG tablet
- MUPIDERM Mupirocin · 2% cream, 2% ointment
- NISITA Daclatasvir · 60 mg tablet
- NORADIL Amlodipine · 10 mg tablet, 5 mg tablet
- PARTAM Paracetamol · 120 mg/5 mL solution, 500 mg tablet
- PROGREL Clopidogrel · 75 mg tablet
- RAPICORT Prednisolone · 15 mg/5 mL solution, 5 mg tablet
- REVERTA Lopinavir + Ritonavir · 200 mg + 50 mg tablet
- RONIL Ceftriaxone · 250 mg injection, 500 mg injection
- RONIL RA Ceftriaxone · 1 G injection
- SCABRID Permethrin · 5 % lotion, 5% lotion, 5% cream
- SIPZ Sodium chloride · 3.5 g sachet
- SUINT Ivermectin · 6 mg tablet
- TABROFEN Ibuprofen · 200 mg tablet, 600 mg tablet
- TABROGYL Metronidazole · 200 mg tablet, 200 mg/5 mL suspension, 400 mg tablet
- TABROPHAGE Metformin · 500 mg tablet
- Tivrox Tranexamic acid · 250 mg/5 mL injection, 500 mg/5 mL injection
- TRYGIL Nitroglycerin · 2.6 mg tablet, 6.4 mg tablet
- TYMZ Misoprostol · 200 mcg tablet
- VIBRENTA Sofosbuvir · 400 mg tablet
- VIBRENTA-VPT 400mg Sofosbuvir + Velpatasvir · 400 mg + 100 mg tablet
- VIRENTA Entecavir · 0.5 mg tablet
- VIZOR Levofloxacin · 250 mg tablet, 500 MG tablet
- Water for Injection Water for Injection · 5 mL injection
- ZATRIK (Low Osmolarity ORS) Sodium chloride + Sodium citrate + Potassium chloride + Glucose · 1.3 g + 1.45 g + 0.75 g + 6.75 g sachet
- Zatron Ceftazidime · 1 g injection, 250 mg injection, 500 mg injection
- ZINGER Ribavirin · 100 mg capsule, 200 mg capsule, 400 mg capsule
TABROS PHARMA: common questions
How many products does TABROS PHARMA have in Pakistan?
TABROS PHARMA (PVT). LTD has 177 registered medicine presentations in Pakistan, sold under 77 brands and covering 64 generic medicines.
What are the main brands of TABROS PHARMA?
By number of registered strengths and packs, its largest brands are DENCITY (Ondansetron), LIZOTEK (Linezolid), Colimethate (Colistimethate sodium), CUTIS (Terbinafine) and FERRY (Iron polymaltose complex). This is not a sales ranking.
Which therapy areas does TABROS PHARMA cover?
The most products are in Anti-infectives (93), Cardiovascular (17), Vitamins, minerals & nutrition (16), Gastrointestinal & hepatology (12) and Hematology & thrombosis (9).
Where can I see TABROS PHARMA medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.